哒螨灵 | 96489-71-3

• 物质功能分类: 化学农药原药 - 杀虫剂 - 杀螨剂
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 哒螨灵
• 中文别名: 速螨酮；2-特丁基-5-(4-特丁基苄硫基-4-氯-3(H)-哒嗪-3-酮；哒螨净；达螨灵：扫螨净；2-特丁基-5-(4-特丁基苄硫基)-4-氯-2H-哒嗪-3-酮；哒螨酮；速螨灵；特螨酮；牵牛星；2-特丁基-5-(4-特丁苄基)硫代-4-氯-3(2氢)-哒嗪酮；2-特丁基5-(4-特丁基苄硫基)-4-氯-哒嗪-3-(2H)酮；95%哒螨灵原药；扫螨净；2-叔丁基-5-(4-叔丁基苄硫基)-4-氯哒嗪-3-(2H)酮
• 英文名称: pyridaben
• 英文别名: 2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one；4-chloro-2-(1,1-dimethylethyl)-5-(((4-(1,1-dimethylethyl)phenyl)methyl)thio)-3(2H)-pyridazinone；2-tert-butyl-4-chloro-5-(4-tert-butyl-benzylthio)-3(2H)-pyridazinone；2-tert-butyl-5-[(4-tert-butylphenyl)methylsulfanyl]-4-chloropyridazin-3-one
• CAS: 96489-71-3
• 化学式: C₁₉H₂₅ClN₂OS
• mdl: MFCD00274601
• 分子量: 364.939
• InChiKey: DWFZBUWUXWZWKD-UHFFFAOYSA-N

物化性质

• 熔点：
  111-112°
• 沸点：
  429.9±55.0 °C(Predicted)
• 密度：
  1.2 g/cm3
• 溶解度：
  氯仿：微溶
• LogP：
  6.370
• 颜色/状态：
  Colorless crystals
• 气味：
  Odorless
• 蒸汽压力：
  1.18X10-6 mm Hg @ 20 °C
• 稳定性/保质期：
  在常温常压下保持稳定，应避免与强氧化剂接触。对眼睛和皮肤无刺激性，并且不会引起豚鼠皮肤过敏。
• 保留指数：
  2652.1;2621.5

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.473
• 拓扑面积：
  58
• 氢给体数：
  0
• 氢受体数：
  3

ADMET

代谢

在大鼠口服代谢研究中，吡啶苯主要通过粪便排出，其中80-97%的给药剂量被排出，无论剂量或标记部位（吡啶唑酮或苄基环）。粪便中排出的残留物中，近20%为未代谢的母化合物，胆汁中有一些葡萄糖醛酸苷结合物的证据。单次低剂量口服（3 mg/kg）后，血浆水平在2-3小时达到峰值，而高剂量（30 mg/kg）的峰值水平在大约24小时后，这部分是由于肠肝循环，其中近22-30%的放射性剂量在24小时内通过胆汁排出。大多数组织的残留放射性在72-168小时后降至或接近背景水平。总体来看，随着时间的推移，脂肪组织的分布似乎有所增加，与其它组织相比，脂肪组织似乎有更多的残留放射性。

In a... rat metabolism study by the oral route, pyridaben was mainly eliminated in feces where 80-97% of the administered dose was excreted regardless of dose or site of label (pyridazinone or benzyl ring). Nearly 20% of the excreted residue in the feces was unmetabolized parent compound and there was some evidence of glucuronide conjugate(s) in the bile. The plasma levels following a single low oral dose (3 mg/kg) peaked at 2-3 hours while peak levels at the high dose (30 mg/kg) were at approximately 24 hours post-dose due, at least in part, to enterohepatic circulation where nearly 22-30% of an administered radioactive dose is excreted in bile within a period of 24 hours. Residual radioactivity was at or near background levels for most tissues by 72-168 hours. Generally, there seemed to be increased distribution to fat over time and, compared to other tissues, fat seemed to have relatively more residual radioactivity.

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 致癌性证据

癌症分类：人类非致癌性证据E组

Cancer Classification: Group E Evidence of Non-carcinogenicity for Humans

来源:Hazardous Substances Data Bank (HSDB)

毒理性

• 致癌物分类

对人类无致癌性（未列入国际癌症研究机构IARC清单）。

No indication of carcinogenicity to humans (not listed by IARC).

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 毒性数据

大鼠LC50 = 620 mg/m³

LC50 (rat) = 620 mg/m3

来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

毒理性

• 毒性数据

LD50：161毫克/千克（急性，大鼠）(L2092)

LD50: 161 mg/kg (acute, rat) (L2092)

来源:Toxin and Toxin Target Database (T3DB)

毒理性

• 解毒与急救

基本治疗：建立专利气道。如有必要，进行吸痰。观察呼吸不足的迹象，如有需要，协助通气。通过非循环呼吸面罩以10至15升/分钟的速度给予氧气。监测肺水肿，如有必要进行治疗……。监测休克，如有必要进行治疗……。预见并处理癫痫发作……。对于眼睛污染，立即用水冲洗眼睛。在运输过程中，用生理盐水连续冲洗每只眼睛……。不要使用催吐剂。对于摄入，如果患者能吞咽、有强烈的干呕反射且不流口水，则用水冲洗口腔，并给予5毫升/千克，最多200毫升的水进行稀释……。在去污后，用干燥的无菌敷料覆盖皮肤烧伤……。/毒药A和B/

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poison A and B/

来源:Hazardous Substances Data Bank (HSDB)

吸收、分配和排泄

在大鼠口服代谢研究中，吡啶苯主要通过粪便排出，其中80-97%的给药剂量被排出，无论剂量或标记位置（吡啶酮或苄基环）。粪便中排出的残留物中，近20%为未代谢的母化合物，胆汁中有一些葡萄糖醛酸苷结合物的证据。单次低剂量口服（3 mg/kg）后，血浆水平在2-3小时达到峰值，而高剂量（30 mg/kg）的峰值水平在大约24小时后，这部分是由于肠肝循环，其中近22-30%的放射性剂量在24小时内通过胆汁排出。大部分组织的残留放射性在72-168小时后达到或接近本底水平。总体来看，随着时间的推移，脂肪组织的分布似乎有所增加，与其他组织相比，脂肪组织似乎有更多的残留放射性。

In a... rat metabolism study by the oral route, pyridaben was mainly eliminated in feces where 80-97% of the administered dose was excreted regardless of dose or site of label (pyridazinone or benzyl ring). Nearly 20% of the excreted residue in the feces was unmetabolized parent compound and there was some evidence of glucuronide conjugate(s) in the bile. The plasma levels following a single low oral dose (3 mg/kg) peaked at 2-3 hours while peak levels at the high dose (30 mg/kg) were at approximately 24 hours post-dose due, at least in part, to enterohepatic circulation where nearly 22-30% of an administered radioactive dose is excreted in bile within a period of 24 hours. Residual radioactivity was at or near background levels for most tissues by 72-168 hours. Generally, there seemed to be increased distribution to fat over time and, compared to other tissues, fat seemed to have relatively more residual radioactivity.

来源:Hazardous Substances Data Bank (HSDB)

安全信息

• 危险等级：
  6.1(a)
• 危险品标志：
  T,N
• 安全说明：
  S36/37,S45,S60,S61
• 危险类别码：
  R50/53,R23/25
• WGK Germany：
  3
• 危险品运输编号：
  UN 3077
• RTECS号：
  UR6149000
• 海关编码：
  2933399027
• 包装等级：
  II
• 危险类别：
  6.1(a)

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : Pyridaben
CAS-No. : 96489-71-3
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Acute toxicity, Inhalation (Category 3)
Acute toxicity, Oral (Category 3)
Acute aquatic toxicity (Category 1)
Chronic aquatic toxicity (Category 1)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Toxic by inhalation and if swallowed. Very toxic to aquatic organisms, may cause long-term adverse effects
in the aquatic environment.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Danger
Hazard statement(s)
H301 Toxic if swallowed.
H331 Toxic if inhaled.
H410 Very toxic to aquatic life with long lasting effects.
Precautionary statement(s)
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P273 Avoid release to the environment.
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/
physician.
P311 Call a POISON CENTER or doctor/ physician.
P501 Dispose of contents/ container to an approved waste disposal plant.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R23/25 Toxic by inhalation and if swallowed.
R50/53 Very toxic to aquatic organisms, may cause long-term adverse effects in
the aquatic environment.
S-phrase(s)
S36/37 Wear suitable protective clothing and gloves.
S45 In case of accident or if you feel unwell, seek medical advice immediately
(show the label where possible).
S60 This material and its container must be disposed of as hazardous waste.
S61 Avoid release to the environment. Refer to special instructions/ Safety
data sheets.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C19H25ClN2OS
Molecular Weight : 364,93 g/mol
Component Concentration
2-tert-Butyl-5-(4-tert-butylbenzylthio)-4-chloro-pyridazine-3(2H)-one
CAS-No. 96489-71-3 -
EC-No. 405-700-3
Index-No. 613-149-00-7

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx), Sulphur oxides, Hydrogen chloride gas
Nature of decomposition products not known.
Carbon oxides, nitrogen oxides (NOx), Sulphur oxides, Hydrogen chloride gas
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate
ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling
the product.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle
respirator type N99 (US) or type P2 (EN 143) respirator cartridges as a backup to engineering
controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use
respirators and components tested and approved under appropriate government standards such
as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
LD50 Oral - mouse - 205 mg/kg
Remarks: Behavioral:Somnolence (general depressed activity). Respiratory disorder Skin and
Appendages: Other: Hair.
LC50 Inhalation - rat - 620 mg/m3
LD50 Dermal - rabbit - > 2.000 mg/kg
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
Reproductive toxicity - rat - Oral
Maternal Effects: Other effects. Effects on Embryo or Fetus: Extra embryonic structures (e.g., placenta,
umbilical cord). Effects on Embryo or Fetus: Fetotoxicity (except death, e.g., stunted fetus).
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation
Toxic if inhaled. May cause respiratory tract irritation.
Ingestion Toxic if swallowed.
Skin
May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Additional Information
RTECS: UR6149000

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
Toxicity to fish LC50 - Oncorhynchus mykiss (rainbow trout) - 0,72 µg/l - 96,0 h
Toxicity to daphnia and EC50 - Daphnia magna (Water flea) - 0,53 µg/l - 48 h
other aquatic
invertebrates
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
Very toxic to aquatic life with long lasting effects.

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: 3077 IMDG: 3077 IATA: 3077
UN proper shipping name
ADR/RID: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (2-tert-Butyl-5-(4-tert-
butylbenzylthio)-4-chloro-pyridazine-3(2H)-one)
IMDG: ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (2-tert-Butyl-5-(4-tert-
butylbenzylthio)-4-chloro-pyridazine-3(2H)-one)
IATA: Environmentally hazardous substance, solid, n.o.s. (2-tert-Butyl-5-(4-tert-butylbenzylthio)-4-
chloro-pyridazine-3(2H)-one)
Transport hazard class(es)
ADR/RID: 9 IMDG: 9 IATA: 9
Packaging group
ADR/RID: III IMDG: III IATA: III
Environmental hazards
ADR/RID: yes IMDG Marine pollutant: yes IATA: yes
Special precautions for user
Further information
EHS-Mark required (ADR 2.2.9.1.10, IMDG code 2.10.3) for single packagings and combination
packagings containing inner packagings with Dangerous Goods > 5L for liquids or > 5kg for solids.

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

---

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

制备方法与用途

杀螨剂——哒螨灵（pyridaben）

哒螨灵（Pyridaben）是1985年由日本日产化学公司开发的杀螨剂，又名速螨酮、达螨酮或牵牛星。该产品于1988年11月在美国布赖顿作物保护会议上正式推出。作为一种速效广谱性杀螨剂，哒螨灵对哺乳动物相对安全，但对水生生物剧毒，并可能影响蜜蜂及家蚕。

性能

• 物理性质：纯品为白色无味结晶固体，熔点111～112℃，相对密度1.22（20℃），蒸汽压极低。溶解度为丙酮460g/L、二甲苯390g/L、苯110g/L等。
• 化学稳定性：在大多数有机溶剂中稳定，在光下不稳定。

用途

哒螨灵主要用于防治棉花、柑橘、果树等经济作物上的各种害虫及螨类。

生产方法 制备方法一

1. 对特丁基甲苯通过偶氮二异丁腈催化，氯化6小时后得对特丁基氯苄。
2. 以甲苯为溶剂，在四丁基溴化铵和醋酸存在下滴加硫氢化钠水溶液反应30分钟，制备对特丁基苄硫醇。

制备方法二

详细步骤未提供。

制备方法三

详细步骤未提供。

性能与用途总结

• 物理性质：白色无味结晶固体。
• 溶解度：极性有机溶剂中溶解良好，水中的溶解度很低。
• 化学稳定性：在有机溶剂中稳定，在光照下不稳定。

安全及残留

• 对环境的影响：剧毒对水生生物，并可能影响蜜蜂与家蚕。需远离水源和桑园使用。

此杀螨剂因其高效率，被广泛应用于农业领域以防治害虫和螨类。但在出口时，应注意遵守相关法规关于其在农产品中的残留限制。

反应信息

• 作为反应物：
  描述：

  哒螨灵 在 potassium [¹⁸F]fluoride 、 potassium carbonate 、 4,7,13,16,21,24-六氧-1,10-二氮双环[8.8.8]二十六烷 作用下， 以 (18O)water 、 水 、 乙腈 为溶剂， 反应 0.5h， 生成 2-tert-butyl-4-[18F]-fluoro-5-(4-tert-butylbenzyl)-thio-3(2H)-pyridazinone
  参考文献：
  名称：

  Contrast agents for myocardial perfusion imaging

  摘要：

  本公开涉及部分用于心肌灌注成像的化合物和方法，包括向患者注射一种对MC-1结合的化合物和成像基团构成的造影剂，并利用诊断成像对患者进行扫描。

  公开号：

  US20050191238A1
• 作为产物：
  描述：

  4-氯-2-(1,1-二甲基乙基)-5-疏基-3(2H)-吡嗪酮 生成 哒螨灵
  参考文献：
  名称：

  MASAKAZU;MASALKAZU;HIROSE, MASAYOSHI;BABA, MASATOSHI;HIRATA, KIMINORI;OCH+

  摘要：

  DOI：
• 作为试剂：
  描述：

  乙酸酐 、 2-amino-3',5'-bis(O-t-butyldimethylsilyl)-β-D-arabinofurano<1',2':4,5>-2-oxazoline 在 哒螨灵 作用下， 反应 12.0h， 生成 N-((3aR,5R,6R,6aS)-6-((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)-3a,5,6,6a-tetrahydrofuro[2,3-d]oxazol-2-yl)acetamide
  参考文献：
  名称：

  [EN] OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
  [FR] COMPOSITIONS D'OLIGONUCLÉOTIDES ET PROCÉDÉS ASSOCIÉS

  摘要：

  除其他事项外，本公开提供寡核苷酸及其组合物。在某些实施例中，提供的寡核苷酸及其组合物对腺苷修饰有用。在某些实施例中，本公开提供了治疗各种需要腺苷修饰的疾病、疾病或病症的方法。

  公开号：

  WO2022099159A1

文献信息

• [EN] BICYCLYL-SUBSTITUTED ISOTHIAZOLINE COMPOUNDS<br/>[FR] COMPOSÉS ISOTHIAZOLINE SUBSTITUÉS PAR UN BICYCLYLE
  申请人：BASF SE

  公开号：WO2014206910A1

  公开（公告）日：2014-12-31

  The present invention relates to bicyclyl-substituted isothiazoline compounds of formula (I) wherein the variables are as defined in the claims and description. The compounds are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.

  本发明涉及公式（I）中变量如索权和说明中所定义的自行车基取代异噻唑啉化合物。这些化合物对抗或控制无脊椎动物害虫，特别是节肢动物害虫和线虫方面具有用途。该发明还涉及一种通过使用这些化合物来控制无脊椎动物害虫的方法，以及包含所述化合物的植物繁殖材料、农业和兽医组合物。
• [EN] AZOLINE COMPOUNDS<br/>[FR] COMPOSÉS AZOLINE
  申请人：BASF SE

  公开号：WO2015128358A1

  公开（公告）日：2015-09-03

  The present invention relates to azoline compounds of formula (I) wherein A, B1, B2, B3, G1, G2, X1, R1, R3a, R3b, Rg1 and Rg2 are as defined in the claims and the description. The compounds are useful for combating or controlling invertebrate pests, in particular arthropod pests and nematodes. The invention also relates to a method for controlling invertebrate pests by using these compounds and to plant propagation material and to an agricultural and a veterinary composition comprising said compounds.

  本发明涉及式（I）的噁唑啉化合物，其中A、B1、B2、B3、G1、G2、X1、R1、R3a、R3b、Rg1和Rg2如权利要求和描述中所定义。这些化合物对抗或控制无脊椎动物害虫，特别是节肢动物害虫和线虫方面具有用途。该发明还涉及一种利用这些化合物控制无脊椎动物害虫的方法，以及包括所述化合物的植物繁殖材料、农业和兽医组合物。
• [EN] MICROBIOCIDAL OXADIAZOLE DERIVATIVES<br/>[FR] DÉRIVÉS D'OXADIAZOLE MICROBIOCIDES
  申请人：SYNGENTA PARTICIPATIONS AG

  公开号：WO2017157962A1

  公开（公告）日：2017-09-21

  Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially fungicides.

  式(I)的化合物，其中取代基如权利要求1所定义，作为杀虫剂特别是杀菌剂有用。
• Thieno-pyrimidine compounds having fungicidal activity
  申请人：Brewster Kirkland William

  公开号：US20070093498A1

  公开（公告）日：2007-04-26

  The present invention relates to thieno[2,3-d]-pyrimidine compounds having fungicidal activity.

  本发明涉及具有杀真菌活性的噻吩[2,3-d]-嘧啶化合物。
• [EN] INSECTICIDAL TRIAZINONE DERIVATIVES<br/>[FR] DÉRIVÉS DE TRIAZINONE INSECTICIDES
  申请人：SYNGENTA PARTICIPATIONS AG

  公开号：WO2013079350A1

  公开（公告）日：2013-06-06

  Compounds of the formula (I) or (I'), wherein the substituents are as defined in claim 1, are useful as pesticides.

  式(I)或(I')的化合物，其中取代基如权利要求1所定义的那样，可用作杀虫剂。

表征谱图